ChiRex signs intemediates deal with MIT
31 August 1998 00:00 [Source: ICB]
ChiRex has signed an exclusive licensing agreement with the Massachusetts Institute of Technology (MIT) to use MIT's metal-catalysed aromatic carbon-heteroatom bond-forming technologies (ABT) for use in the production of pharmaceutical and agrochemical intermediates. ChiRex expects the ABT technology to reduce the complexity and cost of manufacture of intermediates as well as improving purity.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|
Subscribe Today Sample issue >> My Account/Renew >> Register for online access >> |
| ICIS Top 100 Chemical Companies |
|
|
Related Articles
- 12 Mar 12 12:00 Johnson Matthey has been granted a global licence
- 02 Jun 03 00:00 Catalysts Market Attracts Chemical Start-Ups
- 09 Dec 02 00:00 Chiral Technologies Put a New Spin on the Fine Chemicals Toolbox
- 23 Jul 02 16:57 Bayer and Rhodia Chirex forge key technology links
- 15 Jul 02 00:00 MIT signs technology deal
- 30 May 02 00:00 Key movers
- 26 Mar 02 00:00 Nobel causes
- 01 Nov 01 00:00 A promising partnership
- 01 Nov 01 00:00 A promising partnership
- 01 Sep 00 00:00 Rapid developments
Latest News
- 20 May 13 22:46 US spot ethylene solidifies slide after supply-based surge
- 20 May 13 22:35 Business economists increasingly optimistic about US recovery
- 20 May 13 22:25 Epoxidised soybean oil gains as plasticizer in Latin America
- 20 May 13 22:15 US court estimates that RPM units owe $1.17bn in asbestos claims
- 20 May 13 22:14 Q1 Brazil’s consumption of plastic products up by 8% over Q1 2012